BOM:506414 (India)
Â
Shs Dematerialised
₹
379.35
(-0.16%)
Dec 26
Business Description
Fermenta Biotech Ltd
ISIN : INE225B01021
Share Class Description:
BOM:506414: Shs DematerialisedCompare
Compare
Traded in other countries / regions
506414.India IPO Date
2000-02-05Description
Fermenta Biotech Ltd is engaged in the business of manufacturing and marketing chemicals, bulk drugs, enzymes, pharmaceutical formulations, and environmental solution products and renting and selling properties. It is a manufacturer and supplier of Vitamin D and also supplies Penicillin G Amidase, CAL B Lipase, Polymer Supports, and enzyme technologies. The company operates in two segments that are Property and Bulk Drugs/Chemicals. The majority of the revenue comes from the Bulk Drug/Chemicals segment. Geographically, it caters to both domestic and international markets and generates maximum revenue from the Indian market.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.3 | |||||
| Equity-to-Asset | 0.54 | |||||
| Debt-to-Equity | 0.43 | |||||
| Debt-to-EBITDA | 1.99 | |||||
| Interest Coverage | 2.16 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 3.68 | |||||
| Beneish M-Score | -3.09 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -3.7 | |||||
| 3-Year EBITDA Growth Rate | -29.6 | |||||
| 3-Year FCF Growth Rate | 126.9 | |||||
| 3-Year Book Growth Rate | -7.2 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 26.43 | |||||
| 9-Day RSI | 43.65 | |||||
| 14-Day RSI | 51.09 | |||||
| 6-1 Month Momentum % | 119.53 | |||||
| 12-1 Month Momentum % | 140.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.33 | |||||
| Quick Ratio | 0.78 | |||||
| Cash Ratio | 0.2 | |||||
| Days Inventory | 263.36 | |||||
| Days Sales Outstanding | 64.27 | |||||
| Days Payable | 181.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.33 | |||||
| Dividend Payout Ratio | 0.42 | |||||
| Forward Dividend Yield % | 0.33 | |||||
| 5-Year Yield-on-Cost % | 0.33 | |||||
| Shareholder Yield % | 6.06 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 62.64 | |||||
| Operating Margin % | 8.6 | |||||
| Net Margin % | 2.31 | |||||
| FCF Margin % | 23.45 | |||||
| ROE % | 2.94 | |||||
| ROA % | 1.51 | |||||
| ROIC % | 2.45 | |||||
| ROC (Joel Greenblatt) % | 10.86 | |||||
| ROCE % | 10.22 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 129.04 | |||||
| PE Ratio without NRI | 126.07 | |||||
| Shiller PE Ratio | 39.04 | |||||
| Price-to-Owner-Earnings | 382.42 | |||||
| PS Ratio | 3.03 | |||||
| PB Ratio | 3.79 | |||||
| Price-to-Tangible-Book | 3.92 | |||||
| Price-to-Free-Cash-Flow | 12.85 | |||||
| Price-to-Operating-Cash-Flow | 10.51 | |||||
| EV-to-EBIT | 31.63 | |||||
| EV-to-EBITDA | 18.94 | |||||
| EV-to-Revenue | 3.23 | |||||
| EV-to-FCF | 13.94 | |||||
| Price-to-Projected-FCF | 2.01 | |||||
| Price-to-Median-PS-Value | 1.91 | |||||
| Price-to-Graham-Number | 4.68 | |||||
| Earnings Yield (Greenblatt) % | 3.16 | |||||
| FCF Yield % | 7.82 | |||||
| Forward Rate of Return (Yacktman) % | 20.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Fermenta Biotech Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 3,672.657 | ||
| EPS (TTM) (₹) | 2.94 | ||
| Beta | 0.35 | ||
| Volatility % | 63.02 | ||
| 14-Day RSI | 51.09 | ||
| 14-Day ATR (₹) | 20.780494 | ||
| 20-Day SMA (₹) | 393.12 | ||
| 12-1 Month Momentum % | 140.6 | ||
| 52-Week Range (₹) | 145 - 440 | ||
| Shares Outstanding (Mil) | 29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Fermenta Biotech Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Fermenta Biotech Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Fermenta Biotech Ltd Frequently Asked Questions
What is Fermenta Biotech Ltd(BOM:506414)'s stock price today?
The current price of BOM:506414 is ₹379.35. The 52 week high of BOM:506414 is ₹440.00 and 52 week low is ₹145.00.
When is next earnings date of Fermenta Biotech Ltd(BOM:506414)?
The next earnings date of Fermenta Biotech Ltd(BOM:506414) is .
Does Fermenta Biotech Ltd(BOM:506414) pay dividends? If so, how much?
The Dividend Yield %  of Fermenta Biotech Ltd(BOM:506414) is 0.33% (As of Today), Highest Dividend Payout Ratio of Fermenta Biotech Ltd(BOM:506414) was 1.15. The lowest was 0.01. And the median was 0.1. The  Forward Dividend Yield % of Fermenta Biotech Ltd(BOM:506414) is 0.33%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers